Beruflich Dokumente
Kultur Dokumente
Name of RM :
HQ: Month :
Name of RM :
HQ: Month:
Note:
Mention details of joint work with each individual separately.
If the field staff has changed due to any reason (resignation, promotion, transfer, etc), insert row and include the new person joined.
Do not delete names of people who left from the HQ.
Wockhardt - Spectra
Name of RM :
HQ:
HQ - Performance Summary
(Enter values in Rs. Lakhs) Secondary Sales (Net) at PTS
Targets Primary Sale Secondary Sales
Head Quarter Ach 2012/13 Total (YTD) Total (YTD) % Ach Total (YTD) % Ach.
Jul-12 Aug-12 Sep-12 Oct-12 Nov-12 Dec-12 Jan-13 Feb-13 Mar-13 Jul-12 Aug-12 Sep-12 Oct-12 Nov-12 Dec-12 Jan-13 Feb-13 Mar-13 Jul-12 Aug-12 Sep-12 Oct-12 Nov-12 Dec-12 Jan-13 Feb-13 Mar-13
0.00 0.00 0.0 0.00 0.0
0.00 0.00 0.0 0.00 0.0
0.00 0.00 0.0 0.00 0.0
0.00 0.00 0.0 0.00 0.0
0.00 0.00 0.0 0.00 0.0
0.00 0.00 0.0 0.00 0.0
0.00 0.00 0.0 0.00 0.0
0.00 0.00 0.0 0.00 0.0
RM (Mention HQ) 0 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.0 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.0
Name of RM :
HQ:
Brand Performance-REGION
Month
Brands Sec. Sec. Pri.
(Value) Pri. Sales Pri. Sales Pri. Sales % Growth
Sales Sales Sales
Tgt. Ach. % Ach. (Pri.)
Ach. % Ach. (SPLY)
CEFIWOK-O 0.00 0.00 0 0.00 0 0.00 0
CEFIWOK XL 0.00 0.00 0 0.00 0 0.00 0
CEFIWOK-200 0.00 0.00 0 0.00 0 0.00 0
CEFIWOK OTHERS 0.00 0.00 0 0.00 0 0.00 0
TRAM-PROXYVON CAPS 0.00 0.00 0 0.00 0 0.00 0
TRAM-PROXYVON INJ 0.00 0.00 0 0.00 0 0.00 0
BUTA-PROXYVON CAPS 0.00 0.00 0 0.00 0 0.00 0
BUTA-PROXYVON GEL 0.00 0.00 0 0.00 0 0.00 0
NADIMIX 0.00 0.00 0 0.00 0 0.00 0
B.G.PROT GROUP 0.00 0.00 0 0.00 0 0.00 0
POWERPOD SUSP 0.00 0.00 0 0.00 0 0.00 0
OTHER BRANDS 0.00 0.00 0 0.00 0 0.00 0
0.00 0.00 0 0.00 0 0.00 0
0.00 0.00 0 0.00 0 0.00 0
0.00 0.00 0 0.00 0 0.00 0
0.00 0.00 0 0.00 0 0.00 0
0.00 0.00 0 0.00 0 0.00 0
Total 0.00 0.00 0 0.00 0.00 0
TM
HQ
Month
Brands Sec. Sec. Pri.
Pri. Sales Pri. Sales Pri. Sales % Growth
(Value) Tgt. Ach. % Ach.
Sales Sales Sales
(Pri.)
Ach. % Ach. (SPLY)
CEFIWOK-O 0 0 0
CEFIWOK XL 0 0 0
CEFIWOK-200 0 0 0
CEFIWOK OTHERS 0 0 0
TRAM-PROXYVON CAPS 0 0 0
TRAM-PROXYVON INJ 0 0 0
BUTA-PROXYVON CAPS 0 0 0
BUTA-PROXYVON GEL 0 0 0
NADIMIX 0 0 0
B.G.PROT GROUP 0 0 0
POWERPOD SUSP 0 0 0
OTHER BRANDS 0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
Total 0.00 0.00 0 0.00 0.00 0
TM
HQ
Month
Brands Sec. Sec. Pri.
Pri. Sales Pri. Sales Pri. Sales % Growth
(Value) Tgt. Ach. % Ach.
Sales Sales Sales
(Pri.)
Ach. % Ach. (SPLY)
CEFIWOK-O 0 0 0
CEFIWOK XL 0 0 0
CEFIWOK-200 0 0 0
CEFIWOK OTHERS 0 0 0
TRAM-PROXYVON CAPS 0 0 0
TRAM-PROXYVON INJ 0 0 0
BUTA-PROXYVON CAPS 0 0 0
BUTA-PROXYVON GEL 0 0 0
NADIMIX 0 0 0
B.G.PROT GROUP 0 0 0
POWERPOD SUSP 0 0 0
OTHER BRANDS 0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
Total 0.00 0.00 0 0.00 0.00 0
TM
HQ
Month
Brands Sec. Sec. Pri.
Pri. Sales Pri. Sales Pri. Sales % Growth
(Value) Tgt. Ach. % Ach.
Sales Sales Sales
(Pri.)
Ach. % Ach. (SPLY)
CEFIWOK-O 0 0 0
CEFIWOK XL 0 0 0
CEFIWOK-200 0 0 0
CEFIWOK OTHERS 0 0 0
TRAM-PROXYVON CAPS 0 0 0
TRAM-PROXYVON INJ 0 0 0
BUTA-PROXYVON CAPS 0 0 0
BUTA-PROXYVON GEL 0 0 0
NADIMIX 0 0 0
B.G.PROT GROUP 0 0 0
POWERPOD SUSP 0 0 0
OTHER BRANDS 0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
Total 0.00 0.00 0 0.00 0.00 0
TM
HQ
Month
Brands Sec. Sec. Pri.
Pri. Sales Pri. Sales Pri. Sales % Growth
(Value) Tgt. Ach. % Ach.
Sales Sales Sales
(Pri.)
Ach. % Ach. (SPLY)
CEFIWOK-O 0 0 0
CEFIWOK XL 0 0 0
CEFIWOK-200 0 0 0
CEFIWOK OTHERS 0 0 0
TRAM-PROXYVON CAPS 0 0 0
TRAM-PROXYVON INJ 0 0 0
BUTA-PROXYVON CAPS 0 0 0
BUTA-PROXYVON GEL 0 0 0
NADIMIX 0 0 0
B.G.PROT GROUP 0 0 0
POWERPOD SUSP 0 0 0
OTHER BRANDS 0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
Total 0.00 0.00 0 0.00 0.00 0
TM
HQ
Month
Brands Sec. Sec. Pri.
Pri. Sales Pri. Sales Pri. Sales % Growth
(Value) Tgt. Ach. % Ach.
Sales Sales Sales
(Pri.)
Ach. % Ach. (SPLY)
CEFIWOK-O 0 0 0
CEFIWOK XL 0 0 0
CEFIWOK-200 0 0 0
CEFIWOK OTHERS 0 0 0
TRAM-PROXYVON CAPS 0 0 0
TRAM-PROXYVON INJ 0 0 0
BUTA-PROXYVON CAPS 0 0 0
BUTA-PROXYVON GEL 0 0 0
NADIMIX 0 0 0
B.G.PROT GROUP 0 0 0
POWERPOD SUSP 0 0 0
OTHER BRANDS 0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
Total 0.00 0.00 0 0.00 0.00 0
TM
HQ
Month
Brands Sec. Sec. Pri.
Pri. Sales Pri. Sales Pri. Sales % Growth
(Value) Tgt. Ach. % Ach.
Sales Sales Sales
(Pri.)
Ach. % Ach. (SPLY)
CEFIWOK-O 0 0 0
CEFIWOK XL 0 0 0
CEFIWOK-200 0 0 0
CEFIWOK OTHERS 0 0 0
TRAM-PROXYVON CAPS 0 0 0
TRAM-PROXYVON INJ 0 0 0
BUTA-PROXYVON CAPS 0 0 0
BUTA-PROXYVON GEL 0 0 0
NADIMIX 0 0 0
B.G.PROT GROUP 0 0 0
POWERPOD SUSP 0 0 0
OTHER BRANDS 0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
Total 0.00 0.00 0 0.00 0.00 0
TM
HQ
Month
Brands Sec. Sec. Pri.
Pri. Sales Pri. Sales Pri. Sales % Growth
(Value) Tgt. Ach. % Ach.
Sales Sales Sales
(Pri.)
Ach. % Ach. (SPLY)
CEFIWOK-O 0 0 0
CEFIWOK XL 0 0 0
CEFIWOK-200 0 0 0
CEFIWOK OTHERS 0 0 0
TRAM-PROXYVON CAPS 0 0 0
TRAM-PROXYVON INJ 0 0 0
BUTA-PROXYVON CAPS 0 0 0
BUTA-PROXYVON GEL 0 0 0
NADIMIX 0 0 0
B.G.PROT GROUP 0 0 0
POWERPOD SUSP 0 0 0
OTHER BRANDS 0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
Total 0.00 0.00 0 0.00 0.00 0
YTD
YTD
Sec. % Pri. Pri. Sec. Sec. %
Pri. Sales Pri. Sales
Sales Growth Sales Sales % Sales Sales % Growth
Tgt. (SPLY)
(SPLY) (Sec.) Ach. Ach. Ach. Ach. (Pri.)
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.00 0.0 0.00 0.00 0 0.00 0 0.00 0
YTD
Sec. % Pri. Pri. Sec. Sec. %
Pri. Sales Pri. Sales
Sales Growth Sales Sales % Sales Sales % Growth
Tgt. (SPLY)
(SPLY) (Sec.) Ach. Ach. Ach. Ach. (Pri.)
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.00 0.0 0.00 0.00 0 0.00 0 0.00 0
YTD
Sec. % Pri. Pri. Sec. Sec. %
Pri. Sales Pri. Sales
Sales Growth Sales Sales % Sales Sales % Growth
Tgt. (SPLY)
(SPLY) (Sec.) Ach. Ach. Ach. Ach. (Pri.)
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.00 0.0 0.00 0.00 0 0.00 0 0.00 0
YTD
Sec. % Pri. Pri. Sec. Sec. %
Pri. Sales Pri. Sales
Sales Growth Sales Sales % Sales Sales % Growth
Tgt. (SPLY)
(SPLY) (Sec.) Ach. Ach. Ach. Ach. (Pri.)
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.00 0.0 0.00 0.00 0 0.00 0 0.00 0
YTD
Sec. % Pri. Pri. Sec. Sec. %
Pri. Sales Pri. Sales
Sales Growth Sales Sales % Sales Sales % Growth
Tgt. (SPLY)
(SPLY) (Sec.) Ach. Ach. Ach. Ach. (Pri.)
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.00 0.0 0.00 0.00 0 0.00 0 0.00 0
YTD
Sec. % Pri. Pri. Sec. Sec. %
Pri. Sales Pri. Sales
Sales Growth Sales Sales % Sales Sales % Growth
Tgt. (SPLY)
(SPLY) (Sec.) Ach. Ach. Ach. Ach. (Pri.)
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.00 0.0 0.00 0.00 0 0.00 0 0.00 0
YTD
Sec. % Pri. Pri. Sec. Sec. %
Pri. Sales Pri. Sales
Sales Growth Sales Sales % Sales Sales % Growth
Tgt. (SPLY)
(SPLY) (Sec.) Ach. Ach. Ach. Ach. (Pri.)
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.00 0.0 0.00 0.00 0 0.00 0 0.00 0
%
Sec. Sales
Growth
(SPLY)
(Sec.)
0.00 0.0
0.00 0.0
0.00 0.0
0.00 0.0
0.00 0.0
0.00 0.0
0.00 0.0
0.00 0.0
0.00 0.0
0.00 0.0
0.00 0.0
0.00 0.0
0.00 0.0
0.00 0.0
0.00 0.0
0.00 0.0
0.00 0.0
0.00 0.0
%
Sec. Sales
Growth
(SPLY)
(Sec.)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.00 0.0
%
Sec. Sales
Growth
(SPLY)
(Sec.)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.00 0.0
%
Sec. Sales
Growth
(SPLY)
(Sec.)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.00 0.0
%
Sec. Sales
Growth
(SPLY)
(Sec.)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.00 0.0
%
Sec. Sales
Growth
(SPLY)
(Sec.)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.00 0.0
%
Sec. Sales
Growth
(SPLY)
(Sec.)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.00 0.0
%
Sec. Sales
Growth
(SPLY)
(Sec.)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.00 0.0
Wockhardt - Spectra
Name of RM :
HQ:
Coverage Analysis
Sub Total 0 0 0 0
Apr-12
Core Dr. Coverage Important Dr. Coverage
% Core % DML
Met > Met > % Coverage
Total Dr. Not Met Met Once Total
Twice Once Coverage
Coverage
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0 0.0 0 0 0 0 0.0 0.0
C
Total No. No. of
Call Chemist
of Dr. No. of POB Name of ME : Days
Avg. Call Avg. Not Met
Calls Chemist Worked
Met
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0 0.0 0 0.0 0 0 0
May-12
Core Dr. Coverage Important Dr. Coverage
0 0.0 0
0 0.0 0
0 0.0 0
0 0.0 0
0 0.0 0
0 0.0 0
0 0.0 0
0 0.0 0
0 0.0 0
0 0.0 0
0 0 0 0 0.0 0 0 0 0
overage
Total No.
% DML Call Chemist
% of Dr. No. of POB
Coverage Avg. Call Avg.
Coverage Calls Chemist
Met
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0 0.0 0 0.0 0
Jun-12
Core Dr. Coverage
No. of
Name of ME : Days % Core
Met Met >
Worked Not Met Met Once Total Dr.
Twice Twice
Coverage
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0 0 0 0 0 0.0
Jun-12
Important Dr. Coverage
Total No.
% DML Call
Met > % of Dr. No. of
Not Met Met Once Total Coverage Avg.
Once Coverage Calls Chemist
Met
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0 0 0 0.0 0.0 0 0.0 0
Core Dr. Coverage
No. of
Chemist
POB Name of ME : Days Met Met >
Call Avg. Not Met Met Once
Worked Twice Twice
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0 0.00 0 0 0 0 0
Jul-12
Coverage Important Dr. Coverage
Total No.
% Core % DML
Met > % of Dr.
Total Dr. Not Met Met Once Total Coverage
Once Coverage Calls
Coverage
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0 0 0 0.0 0.0 0
Core Dr. Co
No. of
Call Chemist
No. of POB Name of ME : Days
Avg. Call Avg. Not Met Met Once
Chemist Worked
Met
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0 0.0 0.00 0 0 0
Aug-12
Core Dr. Coverage Important Dr. Coverage
% Core
Met Met > Met > %
Total Dr. Not Met Met Once Total
Twice Twice Once Coverage
Coverage
0 0.0 0 0.0
0 0.0 0 0.0
0 0.0 0 0.0
0 0.0 0 0.0
0 0.0 0 0.0
0 0.0 0 0.0
0 0.0 0 0.0
0 0.0 0 0.0
0 0.0 0 0.0
0 0.0 0 0.0
0 0 0 0.0 0 0 0 0 0.0
Total No. No. of
% DML Call Chemist
of Dr. No. of POB Name of ME : Days
Coverage Avg. Call Avg.
Calls Chemist Worked
Met
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0 0.0 0 0.0 0 0
Sep-12
Core Dr. Coverage Important Dr. Coverage
% Core
Met Met > Met >
Not Met Met Once Total Dr. Not Met Met Once
Twice Twice Once
Coverage
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0 0 0 0 0.0 0 0 0
rtant Dr. Coverage
Total No.
% DML Call Chemist
% of Dr. No. of POB
Total Coverage Avg. Call Avg.
Coverage Calls Chemist
Met
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0 0.0 0 0.0 0.00
Oct-12
Core Dr. Coverage
No. of
Name of ME : Days % Core
Met Met >
Worked Not Met Met Once Total Dr.
Twice Twice
Coverage
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0 0 0 0 0 0.0
Oct-12
Important Dr. Coverage
Total No.
% DML Call
Met > % of Dr. No. of
Not Met Met Once Total Coverage Avg.
Once Coverage Calls Chemist
Met
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0 0 0 0.0 0.0 0 0.0 0
Core Dr. Coverage
No. of
Chemist
POB Name of ME : Days Met Met >
Call Avg. Not Met Met Once
Worked Twice Twice
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0 0 0 0 0 0 0
Nov-12
Coverage Important Dr. Coverage
Total No.
% Core % DML
Met > % of Dr.
Total Dr. Not Met Met Once Total Coverage
Once Coverage Calls
Coverage
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0 0 0 0.0 0.0 0
Core Dr. Coverage
No. of
Call Chemist
No. of POB Name of ME : Days Met
Avg. Call Avg. Not Met Met Once
Chemist Worked Twice
Met
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0 0.0 0 0 0 0 0
Dec-12
Core Dr. Coverage Important Dr. Coverage
% Core % DML
Met > Met > % Coverage
Total Dr. Not Met Met Once Total
Twice Once Coverage
Coverage
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0 0.0 0 0 0 0 0.0 0.0
Core Dr. Coverage
Total No. No. of
Call Chemist
of Dr. No. of POB Name of ME : Days
Avg. Call Avg. Not Met Met Once
Calls Chemist Worked
Met
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0 0.0 0 0.0 0.00 0 0 0
Jan-13
Core Dr. Coverage Important Dr. Coverage
% Core
Met Met > Met > %
Total Dr. Not Met Met Once Total
Twice Twice Once Coverage
Coverage
0 0.0 0 0.0
0 0.0 0 0.0
0 0.0 0 0.0
0 0.0 0 0.0
0 0.0 0 0.0
0 0.0 0 0.0
0 0.0 0 0.0
0 0.0 0 0.0
0 0.0 0 0.0
0 0.0 0 0.0
0 0 0 0.0 0 0 0 0 0.0
106 162
Core Dr.
Total No. No. of
% DML Call Chemist
of Dr. No. of POB Name of ME : Days
Coverage Avg. Call Avg. Not Met
Calls Chemist Worked
Met
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0 0.0 0 0.0 0.00 0 0
Feb-13
Core Dr. Coverage Important Dr. Coverage
% Core
Met Met > Met >
Met Once Total Dr. Not Met Met Once Total
Twice Twice Once
Coverage
0 0.0 0
0 0.0 0
0 0.0 0
0 0.0 0
0 0.0 0
0 0.0 0
0 0.0 0
0 0.0 0
0 0.0 0
0 0.0 0
0 0 0 0 0.0 0 0 0 0
overage
Total No. No. of
% DML Call Chemist
% of Dr. No. of POB Name of ME : Days
Coverage Avg. Call Avg.
Coverage Calls Chemist Worked
Met
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0 0.0 0 0.0 0.00 0
Mar-13
Core Dr. Coverage Important Dr. Coverage
% Core
Met Met > Met >
Not Met Met Once Total Dr. Not Met Met Once
Twice Twice Once
Coverage
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0 0 0 0 0.0 0 0 0
rtant Dr. Coverage
Total No.
% DML Call Chemist
% of Dr. No. of POB
Total Coverage Avg. Call Avg.
Coverage Calls Chemist
Met
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0 0.0 0 0.0 0.00
Wockhardt - Spectra
Name of RM :
HQ:
ROB Analysis
Aug-12
POWERCEF
H.Q No. of ROB Units on ROB Last Mth Sec Current Sec Impact
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
FLOXUR OZ Count 2 susp as 1 strip
Aug-12
FLOXUR-OZ POWERCEF
Name of RM :
HQ:
CEFIWOK O/XL/PMS TR